241 related articles for article (PubMed ID: 10540043)
21. Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors.
Lorenzo I; Fernández-de-Larrea N; Michel A; Romero B; Lope V; Bessa X; Moreno V; Martín V; Amiano P; Castilla J; Tardón A; Dierssen-Sotos T; Peiró R; Díaz-Santos M; Navarro C; Jiménez-Moleón JJ; Butt J; Barricarte A; Ruiz I; Molina-de-la-Torre AJ; Casabonne D; Pérez-Gómez B; Kogevinas M; Del Campo R; de Sanjosé S; Pollán M; Waterboer T; Aragonés N
Eur J Cancer Prev; 2019 Jul; 28(4):294-303. PubMed ID: 30489354
[TBL] [Abstract][Full Text] [Related]
22. Carcinogenic Helicobacter pylori in gastric pre-cancer and cancer lesions: association with tobacco-chewing.
Pandey A; Tripathi SC; Mahata S; Vishnoi K; Shukla S; Misra SP; Misra V; Hedau S; Mehrotra R; Dwivedi M; Bharti AC
World J Gastroenterol; 2014 Jun; 20(22):6860-8. PubMed ID: 24944476
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori vacA and cagA genotypes in patients from northeastern Brazil with upper gastrointestinal diseases.
Cavalcante MQ; Silva CI; Braga-Neto MB; Fialho AB; Nunes Fialho A; Barbosa AM; Cruz FW; Rocha GA; Queiroz DM; Braga LL
Mem Inst Oswaldo Cruz; 2012 Jun; 107(4):561-3. PubMed ID: 22666872
[TBL] [Abstract][Full Text] [Related]
24. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma.
Rudi J; Kolb C; Maiwald M; Zuna I; von Herbay A; Galle PR; Stremmel W
Dig Dis Sci; 1997 Aug; 42(8):1652-9. PubMed ID: 9286230
[TBL] [Abstract][Full Text] [Related]
25. Correlation of anti-Helicobacter pylori cagA IgG antibodies with resistance to first line treatment, bleeding gastroduodenal ulcers and gastric cancer.
Ilie M; Dascălu L; Chifiriuc C; Popa M; Constantinescu G; Tănăsescu C; Baltac A
Roum Arch Microbiol Immunol; 2011; 70(3):101-4. PubMed ID: 22570922
[TBL] [Abstract][Full Text] [Related]
26. Association between Helicobacter pylori cytotoxic type I CagA-positive strains and migraine with aura.
Gasbarrini A; Gabrielli M; Fiore G; Candelli M; Bartolozzi F; De Luca A; Cremonini F; Franceschi F; Di Campli C; Armuzzi A; Ojetti V; Serricchio M; Pola R; Gasbarrini G; Giacovazzo M; Pola P
Cephalalgia; 2000 Jul; 20(6):561-5. PubMed ID: 11075839
[TBL] [Abstract][Full Text] [Related]
27. Association of CagA-positive infection with Helicobacter pylori antibodies of IgA class.
Rautelin HI; Oksanen AM; Karttunen RA; Seppälä KM; Virtamo JR; Aromaa AJ; Kosunen TU
Ann Med; 2000 Dec; 32(9):652-6. PubMed ID: 11209973
[TBL] [Abstract][Full Text] [Related]
28. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
29. Country-specific constancy by age in cagA+ proportion of Helicobacter pylori infections.
Pérez-Pérez GI; Bhat N; Gaensbauer J; Fraser A; Taylor DN; Kuipers EJ; Zhang L; You WC; Blaser MJ
Int J Cancer; 1997 Jul; 72(3):453-6. PubMed ID: 9247289
[TBL] [Abstract][Full Text] [Related]
30. Serologic detection of Helicobacter pylori infection with cagA-positive strains in duodenal ulcer, gastric cancer, and asymptomatic gastritis.
Miehlke S; Go MF; Kim JG; Graham DY; Figura N
J Gastroenterol; 1998; 33 Suppl 10():18-21. PubMed ID: 9840011
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study.
Mayr M; Kiechl S; Mendall MA; Willeit J; Wick G; Xu Q
Stroke; 2003 Mar; 34(3):610-5. PubMed ID: 12624280
[TBL] [Abstract][Full Text] [Related]
32. Amino acid polymorphisms flanking the EPIYA-A motif of Helicobacter pylori CagA C-terminal region is associated with gastric cancer in east China: experience from a single center.
Chen CY; Wang FY; Wan HJ; Jin XX; Wei J; Wang ZK; Liu C; Lu H; Shi H; Li DH; Liu J
J Dig Dis; 2013 Jul; 14(7):358-65. PubMed ID: 23517408
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis of the cytotoxin-associated gene and the vacuolating toxin gene in Helicobacter pylori strains isolated from Taiwanese patients.
Yang JC; Wang TH; Wang HJ; Kuo CH; Wang JT; Wang WC
Am J Gastroenterol; 1997 Aug; 92(8):1316-21. PubMed ID: 9260797
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori anti-CagA antibodies: prevalence in symptomatic and asymptomatic subjects in Turkey.
Abasiyanik MF; Sander E; Salih BA
Can J Gastroenterol; 2002 Aug; 16(8):527-32. PubMed ID: 12226680
[TBL] [Abstract][Full Text] [Related]
35. Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains.
Perez-Perez GI; Salomaa A; Kosunen TU; Daverman B; Rautelin H; Aromaa A; Knekt P; Blaser MJ
Gut; 2002 Mar; 50(3):295-8. PubMed ID: 11839704
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori and atrophic gastritis: importance of the cagA status.
Kuipers EJ; Pérez-Pérez GI; Meuwissen SG; Blaser MJ
J Natl Cancer Inst; 1995 Dec; 87(23):1777-80. PubMed ID: 7473834
[TBL] [Abstract][Full Text] [Related]
37. Helicobacter pylori endemic and gastric disease.
Siavoshi F; Malekzadeh R; Daneshmand M; Ashktorab H
Dig Dis Sci; 2005 Nov; 50(11):2075-80. PubMed ID: 16240218
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of
Park JY; Forman D; Waskito LA; Yamaoka Y; Crabtree JE
Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29671784
[TBL] [Abstract][Full Text] [Related]
39. Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States.
Miehlke S; Kibler K; Kim JG; Figura N; Small SM; Graham DY; Go MF
Am J Gastroenterol; 1996 Jul; 91(7):1322-5. PubMed ID: 8677987
[TBL] [Abstract][Full Text] [Related]
40. Clostridium difficile-associated disease and Helicobacter pylori seroprevalence: A case-control study.
Muhsen K; Na'amnih W; Adler A; Carmeli Y; Cohen D
Helicobacter; 2020 Feb; 25(1):e12668. PubMed ID: 31721371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
